康辰药业公告，拟以5000万元-1亿元回购公司股份，回购价格不超过82元/股。本次回购股份全部用于 员工持股计划或股权激励。预计回购股份数量为60.98万股-121.95万股，占公司总股本的0.38%-0.77%。 回购资金来源为公司自有资金或自筹资金，回购期限为董事会审议通过后12个月内。 ...

格隆汇10月15日丨中伟股份(300919.SZ)公布，截至2025年10月15日，公司通过回购专用证券账户以集 中竞价交易方式累计回购股份数量为22,958,992股，约占公司现有总股本的2.45%，最高成交价为41.21 元/股，最低成交价为30.00元/股，累计成交总金额796,560,529.38元（不含佣金、过户费等交易费 用）。公司本次回购股份金额已达回购方案中的回购资金总额下限，且不超过回购方案中的回购资金总 额的上限，本次回购方案已完成。 ...

Core Viewpoint - Tianjin Jiuan Medical Electronics Co., Ltd. has initiated its share repurchase plan, marking a significant step in its financial strategy [1][2]. Group 1: Share Repurchase Details - On October 15, 2025, the company completed its first share repurchase, acquiring 946,400 shares, which represents 0.20% of its total share capital, for a total transaction amount of 37.86 million yuan [1][2]. - The board approved a share repurchase plan on October 13, 2025, with a total funding of no less than 300 million yuan and no more than 600 million yuan, and a maximum repurchase price of 53.5 yuan per share [2]. Group 2: Compliance and Future Disclosures - The company will disclose the share repurchase details on the trading day following the repurchase, in accordance with regulatory guidelines [3]. - Jiuan Medical has committed to not conducting repurchases during periods that could affect stock prices due to significant events, adhering to regulations set by the China Securities Regulatory Commission and Shenzhen Stock Exchange [3].

Core Viewpoint - Shaanxi Light Optical Materials Co., Ltd. has announced an adjustment to the upper limit of the share repurchase price due to a cash dividend distribution plan [1][3]. Summary by Sections Share Repurchase Overview - On April 1, 2025, the company approved a share repurchase plan to buy back part of its issued A-shares using its own funds and a special loan from CITIC Bank Xi'an Branch. The repurchase price was initially set at a maximum of 32.00 CNY per share, with a total repurchase fund not exceeding 100 million CNY and not less than 50 million CNY. The repurchase period is valid for 12 months from the board's approval [2]. Basis for Price Adjustment - The company held a meeting on August 18, 2025, and a temporary shareholders' meeting on September 4, 2025, to approve a cash dividend distribution of 1.80 CNY per 10 shares (including tax). The repurchase price limit will be adjusted according to the cash dividend distribution and any changes in the number of shares due to convertible bonds [3]. Specifics of Price Adjustment - The upper limit for the repurchase price has been adjusted from 31.87 CNY per share to 31.69 CNY per share, effective October 16, 2025. The adjustment formula is based on the cash dividend and the change in circulating shares, which in this case is zero due to no capital increase or stock distribution. The estimated number of shares to be repurchased ranges from approximately 1,577,785 to 3,155,569 shares, representing about 0.39% to 0.78% of the company's total share capital [4].

Group 1 - The company plans to repurchase its shares through centralized bidding, with a total repurchase amount not less than RMB 200 million and not exceeding RMB 400 million [1] - The maximum repurchase price is set at RMB 67.12 per share [1] - The repurchased shares will be used for employee stock ownership plans or equity incentives [1] Group 2 - The repurchase period is within 12 months from the date the board of directors approves the share repurchase plan [1]

恒铭达（002947）(002947.SZ)公告，公司拟回购公司股份用于员工持股计划或者股权激励，本次回购 资金总额不低于2亿元且不超过4亿元，回购股份价格不超过67.12元(含本数)。回购股份期限自董事会审 议通过回购方案之日起不超过12个月。 ...

董事会认为，公司目前的股价低于其真正价值，未能充分反映其业务前景。董事会认为，股份回购计划 显示董事及公司高级管理层对公司的长期增长及市场表现充满信心。董事会亦相信，股份回购计划符合 公司及其股东的整体最佳利益。 格隆汇10月15日丨药师帮(09885.HK)公告，董事会进一步宣布，于2025年10月15日，公司根据2025年股 份回购授权回购股份。合共10万股股份已于市场回购，总回购金额约为111.43万港元(不包括佣金及其 他开支)，平均回购价为每股11.1430港元。回购股份将适时注销。 ...

Core Viewpoint - The company plans to repurchase shares through centralized bidding, with an expected amount of 100 to 200 million yuan, from November 25, 2024, to November 24, 2025 [1] Summary by Relevant Sections - **Share Repurchase Details** - The company will initiate a share repurchase on November 25, 2024, with a budget of 100 to 200 million yuan [1] - The repurchase period is set from November 25, 2024, to November 24, 2025 [1] - **Initial Repurchase Execution** - On October 15, 2025, the company repurchased 4.7985 million shares, representing 0.1157% of the total share capital [1] - The total payment for this initial repurchase was approximately 11.191002 million yuan, with a price range of 2.32 to 2.35 yuan per share [1] - **Purpose of Repurchased Shares** - The repurchased shares will be utilized for employee stock ownership plans or equity incentives [1] - **Disclosure Obligations** - The company will fulfill its information disclosure obligations based on the progress of the share repurchase [1]

Core Viewpoint - The company has repurchased a total of 36.284 million shares, representing approximately 2.94% of its total share capital, as part of its share buyback plan [1] Summary by Categories Share Buyback Details - The repurchase was conducted through a special securities account for share buybacks via centralized bidding [1] - The highest transaction price was 6.08 CNY per share, while the lowest was 5.03 CNY per share [1] - The total amount paid for the buyback was 200 million CNY, including transaction fees [1] Compliance and Funding - The buyback complies with the company's share repurchase plan and relevant laws and regulations [1] - The funding sources for the buyback include the company's own funds and a special loan for share repurchase [1] - The repurchase price did not exceed 7.93 CNY per share [1]

证券日报网讯太阳能10月15日发布公告，在公司回答调研者提问时表示，截至2025年9月底，公司通过 股份回购专用证券账户以集中竞价方式累计回购公司股份10，930，100股，成交总金额约5000万元（不 含交易费用），后续将根据市场动态在回购期限内持续推进实施。 （文章来源：证券日报） ...